A Novel Ruthenium(II) Complex and its Synergistic Anti-Leukemia Activity with GidA Protein via Dual-Pathway Apoptosis
Drug Research · 27.07.2026
DOI: 10.1055/a-2905-1945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 27.07.2026. Verfasst von Antony K T Infanta S und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bharathiar University, Cancer Therapeutics Lab, Microbial Biotechnology, India, Coimbatore.
Abstract (Originalsprache)
AbstractThis study demonstrates the effective anticancer activity of a semi-synthetic complex integrating the GidA protein and the ruthenium(II) complex against K562 human leukemia cells. Monotherapy evaluation revealed exceptional cytotoxicity, with half-maximal inhibitory concentration values of 0.058 μg/mL for GidA (a novel topoisomerase II inhibitor) and 14.1 μg/mL for Ru(II). Subsequently, isobologram analysis of six combination ratios identified profound synergy in formulations with elevated Ru(II) concentrations (combinations 4 and 5; sum of the fractional inhibitory concentration=0.17–0.86). All these synergistic complexes induced up to 73.91% apoptosis, exceeding single-agent efficacy (p
Autor:innen und Institutionen
- Bharathiar University, Cancer Therapeutics Lab, Microbial Biotechnology, India, Coimbatore.
- Vinayaka Missions Research Foundation (Deemed to be University), Medical and Bioresearch, Aarupadai Veedu Medical College and Hospital, Puducherry, India, 607403 Kirumampakkam.
- City University of Hong Kong, Biomedical Engineering, Hong Kong.
- St Peter's Institute of Higher Education and Research, Medical Research, Chennai.
ORCID-Profile: Thandeeswaran Murugesan, Angayarkanni Jayaraman
Zitieren
APA
Infanta S, A. K. T., Murugesan, T., Dhanapal, A. R., Muthuswamy, P., & Jayaraman, A. (2026). A Novel Ruthenium(II) Complex and its Synergistic Anti-Leukemia Activity with GidA Protein via Dual-Pathway Apoptosis. Drug Research. https://doi.org/10.1055/a-2905-1945
Vancouver
Infanta S AKT, Murugesan T, Dhanapal AR, Muthuswamy P, Jayaraman A. A Novel Ruthenium(II) Complex and its Synergistic Anti-Leukemia Activity with GidA Protein via Dual-Pathway Apoptosis. Drug Research. 2026. doi:10.1055/a-2905-1945
BibTeX
@article{InfantaS2026,
author = {Infanta S, Antony K T and Murugesan, Thandeeswaran and Dhanapal, Anand Raj and Muthuswamy, Palaniswamy and Jayaraman, Angayarkanni},
title = {A Novel Ruthenium(II) Complex and its Synergistic Anti-Leukemia Activity with GidA Protein via Dual-Pathway Apoptosis},
journal = {Drug Research},
year = {2026},
doi = {10.1055/a-2905-1945}
}
EUVIMED